Role of complement in the control of HIV dynamics and pathogenesis (Q35134722)

6 August 2017

1 reference

title

Role of complement in the control of HIV dynamics and pathogenesis (English)

1 reference

6 August 2017

2

Cornelia Speth

1 reference

6 August 2017

1

Heribert Stoiber

1 reference

6 August 2017

Manfred P Dierich

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21 Suppl 2

1 reference

6 August 2017

page(s)

S77-82

1 reference

Extrahepatic complement biosynthesis: where, when and why?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Transcriptional regulation of complement genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Expression of complement in the brain: role in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Complement components of the innate immune system in health and disease in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

The supportive role of complement in HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Role of complement in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

A "complement-ary" AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Acquisition of host cell-surface-derived molecules by HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Direct Interaction of Complement Factor H with the C1 Domain of HIV Type 1 Glycoprotein 120

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Quantitative image analysis of HIV-1 infection in lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Follicular dendritic cells and human immunodeficiency virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Germinal centre CD4+ T cells are an important site of HIV replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Molecular cloning and characterization of the human anaphylatoxin C3a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

The chemotactic receptor for human C5a anaphylatoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Neuroinvasion by pathogens: a key role of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

A neuronal C5a receptor and an associated apoptotic signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900203-2

7 January 2021

10.1016/S0264-410X(03)00203-2

Identifiers

DOI

1 reference

6 August 2017

1 reference